Literature DB >> 20117670

Peak flow monitoring in pediatric asthma management: a clinical practice column submission.

Kimberly A Callahan1, Theresa M Panter, Tracy Michelle Hall, Marina Slemmons.   

Abstract

Peak expiratory flow (PEF) monitoring has long been a mainstay of asthma management, but controversy surrounds its efficacy in the pediatric population, and little published research exists on the subject. PEF is both effort and technique dependent and is not suitable for use in children under the age of 5 or with developmental disabilities. However, PEF is useful for monitoring airway changes if used properly, especially in that segment of the population labeled as "poor perceivers" of worsening symptoms. The authors review existing literature on the subject, including the newly revised National Heart, Lung, and Blood Institute (National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services. (2007). Expert panel report 3: Guidelines for the diagnosis and management of asthma-full report 2007. Retrieved June 17, 2008, from http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm) evidence-based guidelines. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20117670     DOI: 10.1016/j.pedn.2008.06.009

Source DB:  PubMed          Journal:  J Pediatr Nurs        ISSN: 0882-5963            Impact factor:   2.145


  5 in total

1.  Peak Expiratory Flow Rate as a Monitoring Tool in Asthma.

Authors:  Krishna Mohan Gulla; S K Kabra
Journal:  Indian J Pediatr       Date:  2017-06-14       Impact factor: 1.967

2.  Effect of peak flow monitoring on child asthma quality of life.

Authors:  Patricia V Burkhart; Mary Kay Rayens; Marsha G Oakley
Journal:  J Pediatr Nurs       Date:  2011-01-19       Impact factor: 2.145

3.  A randomised dose-ranging study of tiotropium Respimat® in children with symptomatic asthma despite inhaled corticosteroids.

Authors:  Christian Vogelberg; Petra Moroni-Zentgraf; Migle Leonaviciute-Klimantaviciene; Ralf Sigmund; Eckard Hamelmann; Michael Engel; Stanley Szefler
Journal:  Respir Res       Date:  2015-02-07

4.  Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials.

Authors:  Lyndon Mansfield; Sy Duong-Quy; Timothy Craig
Journal:  Adv Ther       Date:  2019-08-21       Impact factor: 3.845

5.  Asthma self-management: a study in an emergency room of a chest hospital in delhi, India.

Authors:  Anita Kotwani; Sushil Shendge
Journal:  South Med Rev       Date:  2012-12-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.